These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7658706)

  • 21. Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes.
    Fujii S; Shimizu K; Klimek V; Geller MD; Nimer SD; Dhodapkar MV
    Br J Haematol; 2003 Aug; 122(4):617-22. PubMed ID: 12899717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
    Fozza C; Contini S; Galleu A; Simula MP; Virdis P; Bonfigli S; Longinotti M
    Exp Hematol; 2009 Aug; 37(8):947-55. PubMed ID: 19409953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.
    Vankayalapati R; Klucar P; Wizel B; Weis SE; Samten B; Safi H; Shams H; Barnes PF
    J Immunol; 2004 Jan; 172(1):130-7. PubMed ID: 14688318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinatory effects of hepatic CD8+ and NK lymphocytes in bile duct injury from biliary atresia.
    Guo C; Zhu J; Pu CL; Deng YH; Zhang MM
    Pediatr Res; 2012 Jun; 71(6):638-44. PubMed ID: 22476047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic abnormalities in myelodysplastic syndromes.
    Hamblin T
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):571-86. PubMed ID: 1613007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of interleukin 2 on myelodysplastic syndromes.
    Ogata K; Yokose N; Ito T; An E; Dan K; Nomura T
    Leuk Res; 1993 Feb; 17(2):137-42. PubMed ID: 8429690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct human circulating NKp30
    Correia MP; Stojanovic A; Bauer K; Juraeva D; Tykocinski LO; Lorenz HM; Brors B; Cerwenka A
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5980-E5989. PubMed ID: 29895693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased TIM3+CD8+T cells in Myelodysplastic Syndrome patients displayed less perforin and granzyme B secretion and higher CD95 expression.
    Tao J; Li L; Wang Y; Fu R; Wang H; Shao Z
    Leuk Res; 2016 Dec; 51():49-55. PubMed ID: 27846431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.
    Burkett PR; Koka R; Chien M; Chai S; Boone DL; Ma A
    J Exp Med; 2004 Oct; 200(7):825-34. PubMed ID: 15452177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection.
    Patil NK; Luan L; Bohannon JK; Guo Y; Hernandez A; Fensterheim B; Sherwood ER
    PLoS One; 2016; 11(2):e0148452. PubMed ID: 26859674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis.
    Qian X; Chen H; Wu X; Hu L; Huang Q; Jin Y
    Cytokine; 2017 Jan; 89():34-44. PubMed ID: 26883678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia.
    Gonzalez-Rodriguez AP; Contesti J; Huergo-Zapico L; Lopez-Soto A; Fernández-Guizán A; Acebes-Huerta A; Gonzalez-Huerta AJ; Gonzalez E; Fernandez-Alvarez C; Gonzalez S
    Leuk Lymphoma; 2010 Oct; 51(10):1829-36. PubMed ID: 20846097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression.
    Schluns KS; Nowak EC; Cabrera-Hernandez A; Puddington L; Lefrançois L; Aguila HL
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5616-21. PubMed ID: 15060278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection.
    Björkström NK; Gonzalez VD; Malmberg KJ; Falconer K; Alaeus A; Nowak G; Jorns C; Ericzon BG; Weiland O; Sandberg JK; Ljunggren HG
    J Immunol; 2008 Sep; 181(6):4219-28. PubMed ID: 18768879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
    Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
    J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro.
    Park JH; Hanke T; Hünig T
    Eur J Immunol; 1996 Oct; 26(10):2371-5. PubMed ID: 8898947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
    Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
    Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.